Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | XMT-1660 |
Synonyms | |
Therapy Description |
XMT-1660 is an antibody-drug conjugate (ADC) targeting B7-H4, which potentially inhibits tumor growth (PMID: 37294948). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
XMT-1660 | XMT 1660|XMT1660 | XMT-1660 is an antibody-drug conjugate (ADC) targeting B7-H4, which potentially inhibits tumor growth (PMID: 37294948). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05377996 | Phase I | XMT-1660 | A Study of XMT-1660 in Participants With Solid Tumors | Recruiting | USA | 0 |